https://medicaex.com/prnewswire/decode-genetics-publishes-multiomics-study-of-nonalcoholic-fatty-liver-disease/ 2022-10-31T00:12:42+00:00 https://medicaex.com/wp-content/uploads/2022/10/deCODE_genetics-l1Vvrw.jpeg https://medicaex.com/prnewswire/hinova-disclosed-the-preclinical-results-of-hp518-oral-ar-protac-at-the-5th-annual-tpd-summit/ 2022-10-31T00:12:29+00:00 https://medicaex.com/prnewswire/pharming-announces-european-medicines-agency-ema-validates-its-marketing-authorisation-application-under-accelerated-assessment-for-leniolisib/ 2022-10-30T21:12:53+00:00 https://medicaex.com/wp-content/uploads/2022/10/Pharming_Group_NV_Logo-8GuDuK.jpeg https://medicaex.com/prnewswire/2022-digitisation-in-traditional-medicine-world-summit-successfully-held-in-macau/ 2022-10-29T05:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/10/image_5025772_11772260-AehuJQ.jpeg https://medicaex.com/prnewswire/invivoscribe-files-spma-with-the-fda-for-use-of-the-leukostrat-cdx-flt3-mutation-assay-to-select-patients-with-newly-diagnosed-flt3-itd-positive-aml/ 2022-10-28T22:12:33+00:00 https://medicaex.com/wp-content/uploads/2022/10/Invivoscribe_Logo-pLCm94.jpeg https://medicaex.com/prnewswire/acceptance-of-the-application-for-clinical-trial-of-recbio-novel-adjuvanted-recombinant-quadrivalent-hpv-vaccine/ 2022-10-28T22:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/10/Recbio_Logo-PbYWIV.jpeg https://medicaex.com/prnewswire/prenatal-genetic-testing-market-to-improve-accuracy-through-technological-advances/ 2022-10-28T21:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/10/Prenatal_Genetic_Testing-FYS6jy.jpeg https://medicaex.com/prnewswire/sebela-pharmaceuticals-acquires-exclusive-licensing-rights-to-develop-and-commercialize-tegoprazan-in-the-u-s-and-canada/ 2022-10-28T21:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/10/Sebela_Pharmaceuticals-VkU9gF.jpeg https://medicaex.com/prnewswire/transcenta-to-present-first-in-class-tst003-antibody-program-at-the-10th-temtia-meeting/ 2022-10-28T18:12:34+00:00 https://medicaex.com/prnewswire/harbour-biomed-announces-dosing-of-first-patient-in-phase-i-trial-of-b7h4x4-1bb-bispecific-antibody-in-the-united-states/ 2022-10-28T14:12:42+00:00 https://medicaex.com/wp-content/uploads/2022/10/HB_for_email_Logo-5ndKvD.jpeg https://medicaex.com/prnewswire/nda-for-new-second-line-indication-of-car-t-cell-therapy-product-yikaida-axicabtagene-ciloleucel-injection-approved-for-cde-review/ 2022-10-28T14:12:28+00:00 https://medicaex.com/wp-content/uploads/2022/10/NDA_for_New_Second_Line_Indication_of_CAR_T_Cell_Therapy_Product_YIKAIDA__Axicabtagene_Ciloleucel_In-T9IOy9.jpeg https://medicaex.com/prnewswire/future-of-healthcare-week-asia-building-sustainable-systems-for-all/ 2022-10-28T13:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/10/FOH2022_EI_meme_1200x675_eventphoto_2-ZSaJFC.jpeg https://medicaex.com/prnewswire/life-sciences-industrys-highest-achievers-celebrated-at-prestigious-awards-ceremony/ 2022-10-28T12:12:27+00:00 https://medicaex.com/wp-content/uploads/2022/10/Co_Brand_Event_Full_Colour-hDaHE5.jpeg https://medicaex.com/prnewswire/wuxi-biologics-provides-corporate-updates/ 2022-10-28T12:12:27+00:00 https://medicaex.com/prnewswire/international-experts-recommend-nuts-and-dried-fruits-as-part-of-a-healthy-diet/ 2022-10-28T09:12:16+00:00 https://medicaex.com/prnewswire/stamford-american-celebrates-global-be-well-day-highlighting-the-importance-of-well-being/ 2022-10-28T07:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/10/IMG_3377-lLTrkv.jpeg https://medicaex.com/prnewswire/novel-biocompatible-uv-light-absorber-wpi-mana/ 2022-10-28T07:12:15+00:00 https://medicaex.com/prnewswire/mentice-launches-new-website/ 2022-10-28T06:12:25+00:00 https://medicaex.com/prnewswire/cambrex-to-invest-16-5-million-in-new-rd-facility-in-minneapolis-minnesota-and-expansion-in-charles-city-iowa/ 2022-10-28T03:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/10/Cambrex_Logo-FlEwTZ.jpeg https://medicaex.com/prnewswire/gerresheimer-and-merck-transform-primary-packaging-into-digital-twins/ 2022-10-28T01:12:23+00:00 https://medicaex.com/prnewswire/sciwind-biosciences-announces-positive-interim-results-from-ongoing-phase-2b-clinical-trial-of-xw003-ecnoglutide-in-patients-with-obesity/ 2022-10-28T01:12:21+00:00 https://medicaex.com/prnewswire/antengene-to-host-research-and-development-day-on-november-15th-and-17th-2022/ 2022-10-28T00:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/10/ANTENGENE_EN_Logo-zVzomx.jpeg https://medicaex.com/prnewswire/united-imaging-healthcare-attends-european-association-of-nuclear-medicine-congress-with-uexplorer-the-worlds-first-total-body-pet-ct/ 2022-10-27T15:00:52+00:00 https://medicaex.com/prnewswire/the-evolution-of-u-s-medical-tourism-virtual-summit-insights-and-perspectives/ 2022-10-27T15:00:27+00:00 https://medicaex.com/prnewswire/successful-passing-of-eu-qp-audit-on-tot-biopharms-commercial-production-base-for-monoclonal-antibody-drug-substances-and-antibody-drug-conjugates/ 2022-10-27T14:00:39+00:00 https://medicaex.com/prnewswire/seekin-presents-new-data-supporting-its-pan-cancer-early-detection-test-at-the-early-detection-of-cancer-conference-2022/ 2022-10-27T13:01:03+00:00 https://medicaex.com/prnewswire/aasld-2022-ascentage-pharma-to-announce-results-from-first-in-human-study-of-iap-antagonist-apg-1387-in-an-oral-report-at-the-aasld-annual-meeting/ 2022-10-27T13:01:02+00:00 https://medicaex.com/wp-content/uploads/2022/10/Ascentage_Pharma_Logo-6xIMpP.jpeg https://medicaex.com/prnewswire/samsung-biologics-reports-third-quarter-2022-financial-results/ 2022-10-27T13:00:39+00:00 https://medicaex.com/prnewswire/happiness-development-group-limited-regains-compliance-with-nasdaq-minimum-bid-price-requirement/ 2022-10-27T13:00:28+00:00 https://medicaex.com/prnewswire/tsinghua-sigs-virtual-open-day-2023-where-your-future-starts/ 2022-10-27T10:00:39+00:00 https://medicaex.com/wp-content/uploads/2022/10/Tsinghua_Shenzhen_International_Graduate_School__Tsinghua_SIGS__Virtual_Open_Day-jsRp34.jpeg https://medicaex.com/prnewswire/oncok9-the-pioneering-blood-based-early-cancer-detection-test-for-dogs-now-available-in-asia-through-asia-veterinary-diagnostics/ 2022-10-27T03:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/10/PetDx_Logo__1_Logo-tLX1Vt.jpeg https://medicaex.com/prnewswire/telix-recognised-as-company-of-the-year-at-ausbiotech-and-johnson-johnson-innovation-industry-excellence-awards-2022/ 2022-10-27T03:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/10/Telix_Main_Logo_Logo-vLcTN3.jpeg https://medicaex.com/prnewswire/advanced-instruments-introduces-the-osmopro-max-automated-osmometer-to-maximize-clinical-lab-productivity/ 2022-10-27T02:00:44+00:00 https://medicaex.com/wp-content/uploads/2022/10/Osmopromax-SC3G6H.jpeg https://medicaex.com/prnewswire/sirona-completes-enrollment-a-leap-in-the-dcb-treatment-of-femoropopliteal-arterial-disease/ 2022-10-27T02:00:44+00:00 https://medicaex.com/wp-content/uploads/2022/10/SIRONA_Enrollment-CBLhbw.jpeg https://medicaex.com/prnewswire/wuxi-apptec-reports-record-year-to-date-results-in-2022-third-quarter-revenue-over-rmb10-billion/ 2022-10-27T02:00:34+00:00 https://medicaex.com/prnewswire/alterity-therapeutics-announces-presentation-of-mri-data-from-the-biomuse-natural-history-study-at-the-american-neurological-association-annual-meeting/ 2022-10-27T02:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/10/Alterity_Logo-pQM4sk.jpeg https://medicaex.com/prnewswire/jw-therapeutics-and-2seventy-bio-announce-strategic-partnership-to-accelerate-the-research-and-development-of-t-cell-based-immunotherapies/ 2022-10-27T01:00:44+00:00 https://medicaex.com/wp-content/uploads/2022/10/JW_Logo-cGhYJj.jpeg https://medicaex.com/prnewswire/immvira-announced-its-signing-of-series-c-financing-and-negotiation-with-further-investors-for-the-round/ 2022-10-26T23:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/10/image-kTWkaT.jpeg https://medicaex.com/prnewswire/telix-and-uniquest-to-collaborate-on-radiolabelled-immune-targeting-peptide/ 2022-10-26T23:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/10/Telix_Main_Logo_Logo-EL2e9I.jpeg https://medicaex.com/prnewswire/texas-cardiac-arrhythmia-institute-physician-led-international-workshop-on-cardiac-arrhythmias/ 2022-10-26T15:00:49+00:00 https://medicaex.com/prnewswire/waterdrop-opens-its-first-community-outlet-in-shenzhen-to-explore-the-insurance-community-model/ 2022-10-26T15:00:40+00:00 https://medicaex.com/prnewswire/edan-forays-into-molecular-point-of-care-market-with-its-first-ever-molecular-diagnostics-solution-released-at-medlab-asia-2022/ 2022-10-26T13:01:13+00:00 https://medicaex.com/wp-content/uploads/2022/10/EDAN_s_Molecular_Diagnostics_Analysis_System_ClariLight_CL30_making_debut_today-EFGPEs.jpeg https://medicaex.com/prnewswire/ascletis-announces-u-s-ind-filing-of-oral-antiviral-asc10-for-monkeypox-indication/ 2022-10-26T13:00:55+00:00 https://medicaex.com/prnewswire/alwin-capitals-new-dual-currency-fund-closed-and-exceeded-fundraising-target/ 2022-10-26T12:01:20+00:00 https://medicaex.com/wp-content/uploads/2022/10/Alwin_Capital_Investment_Portfolio-FoIpxg.jpeg https://medicaex.com/prnewswire/wuxi-biologics-announces-gmp-release-of-48000l-commercial-drug-substance-manufacturing-facility-in-hebei-china/ 2022-10-26T11:01:00+00:00 https://medicaex.com/prnewswire/pivalate-achieves-positive-phase-2-data-in-brain-mets-trial/ 2022-10-26T09:01:11+00:00 https://medicaex.com/wp-content/uploads/2022/10/Logo-IKYNFp.jpeg https://medicaex.com/prnewswire/mentices-ceo-goran-malmberg-to-present-the-companys-interim-report-at-a-webcast-conference-call-on-october-26-at-1000-cest/ 2022-10-26T09:01:01+00:00 https://medicaex.com/prnewswire/clarivate-identifies-seven-innovators-in-new-rna-technology-companies-to-watch-report/ 2022-10-26T09:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/10/Clarivate_Logo-qA0674.jpeg https://medicaex.com/prnewswire/singapore-to-host-the-7th-world-one-health-congress/ 2022-10-26T09:00:33+00:00 https://medicaex.com/prnewswire/swesd-2022-the-joint-world-conference-on-social-work-education-and-social-development-to-be-held-in-seoul-for-four-days-starting-26th-oct/ 2022-10-26T08:00:15+00:00 https://medicaex.com/wp-content/uploads/2022/10/2022_JOINT_WORLD_CONFERENCE_ON_SOCIAL_WORK_EDUCATION_AND_SOCIAL_DEVELOPMENT-NPDMvR.jpeg https://medicaex.com/prnewswire/mahidol-university-the-top-university-in-thailand-has-officially-adopted-jolly-goods-medical-vr/ 2022-10-26T07:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/10/Mahidol_University_Top_University_Thailand_Has_Officially_Adopted_Jolly_Good_s-BaXwHU.jpeg https://medicaex.com/prnewswire/biocell-technology-expands-global-presence-and-trust-with-prestigious-halal-certification/ 2022-10-26T06:00:22+00:00 https://medicaex.com/wp-content/uploads/2022/10/BioCell___Halal_Combined_FINAL-GhVtsN.jpeg https://medicaex.com/prnewswire/medalliance-to-be-acquired-by-cordis/ 2022-10-25T15:00:58+00:00 https://medicaex.com/wp-content/uploads/2022/10/MedAlliance_Image-2VyEw4.jpeg https://medicaex.com/prnewswire/revir-therapeutics-expands-research-team-by-appointing-dr-sridhar-narayan-as-head-of-medicinal-chemistry/ 2022-10-25T15:00:43+00:00 https://medicaex.com/prnewswire/carsgen-announces-nda-acceptance-of-bcma-car-t-zevor-cel-ct053-by-china-nmpa/ 2022-10-25T12:01:11+00:00 https://medicaex.com/wp-content/uploads/2022/10/Logo-9DfTFJ.jpeg https://medicaex.com/prnewswire/gracell-biotechnologies-to-participate-in-two-upcoming-investor-conferences/ 2022-10-25T12:00:46+00:00 https://medicaex.com/wp-content/uploads/2022/10/gracell_logo_Logo-q4Vw2f.jpeg https://medicaex.com/prnewswire/transcenta-to-participate-in-four-upcoming-conferences/ 2022-10-25T12:00:46+00:00 https://medicaex.com/prnewswire/zhiyi-biotech-received-clinical-approval-from-u-s-fda-for-sk10-in-chemotherapy-induced-diarrhea/ 2022-10-25T08:00:43+00:00 https://medicaex.com/wp-content/uploads/2022/10/Zhiyi_Biotech-bdPuzO.jpeg https://medicaex.com/prnewswire/indias-most-advanced-and-largest-ivf-clinic-group-indira-ivf-will-offer-all-patients-artificial-intelligence-technology-to-improve-pregnancy-outcomes/ 2022-10-25T07:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/10/Presagen_Logo_Black_Text_Logo-GXvm6B.jpeg https://medicaex.com/prnewswire/eyenuk-secures-26-million-series-a-funding-to-accelerate-global-access-to-ai-powered-eye-screening-technology/ 2022-10-25T04:00:54+00:00 https://medicaex.com/wp-content/uploads/2022/10/EYENUK_LOGO-6f79Jw.jpeg https://medicaex.com/prnewswire/telix-partnership-expands-ge-healthcare-immuno-diagnostics-offering-to-the-global-clinical-research-market/ 2022-10-25T00:00:48+00:00 https://medicaex.com/wp-content/uploads/2022/10/Telix_Pharmaceuticals_Limited_GE-Y7HOVf.jpeg https://medicaex.com/prnewswire/editforce-realizes-rna-editing-technology-of-u-to-c/ 2022-10-24T15:01:04+00:00 https://medicaex.com/prnewswire/inxmed-releases-data-demonstrating-in10018-therapeutic-potential-in-patients-with-metastatic-melanoma-at-smr-2022/ 2022-10-24T15:01:04+00:00 https://medicaex.com/wp-content/uploads/2022/10/InxMed_Logo-WdMUyc.jpeg https://medicaex.com/prnewswire/wuxi-biologics-released-a-new-cgmp-drug-product-manufacturing-facility-to-support-end-to-end-services-for-diversified-modalities/ 2022-10-24T15:00:43+00:00 https://medicaex.com/prnewswire/waterdrop-explores-offline-insurance-brokerage/ 2022-10-24T14:00:30+00:00 https://medicaex.com/prnewswire/3m-v-a-c-therapy-negative-pressure-wound-therapy-achieves-key-medical-evidence-milestone-surpassing-2000-peer-reviewed-medical-journal-studies-published/ 2022-10-24T12:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/10/3M_VAC_Therapy-aw0sn3.jpeg https://medicaex.com/prnewswire/sk-bioscience-appoints-new-executives-towards-global-business-growth/ 2022-10-24T12:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/10/image-4tDCdL.jpeg https://medicaex.com/prnewswire/polaris-dawn-selects-38-science-and-research-experiments-to-advance-human-health-and-space-exploration/ 2022-10-24T12:00:14+00:00 https://medicaex.com/wp-content/uploads/2022/10/Polaris_logo_Logo-KGmIqo.jpeg https://medicaex.com/prnewswire/large-scale-clinical-study-shows-cu-medicine-sim01-microbiome-formula-reduces-risk-of-infections-including-covid-19/ 2022-10-24T11:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/10/20221024_1-Kv0YjC.jpeg https://medicaex.com/prnewswire/ping-an-health-acquires-ping-an-smart-healthcare/ 2022-10-24T09:00:15+00:00 https://medicaex.com/prnewswire/menarini-silicon-biosystemss-cellsearch-cmmc-and-her2-ctc-liquid-biopsy-tests-obtain-reimbursement-codes-with-preliminary-pricing-determination/ 2022-10-24T08:00:37+00:00 https://medicaex.com/wp-content/uploads/2022/10/Menarini_Logo-oL3tu7.jpeg https://medicaex.com/prnewswire/tlx250-cdx-indication-expansion-preliminary-data-presented-at-eanm/ 2022-10-24T07:01:29+00:00 https://medicaex.com/wp-content/uploads/2022/10/Telix_Main_Logo_Logo-vfT543.jpeg https://medicaex.com/prnewswire/alex-therapeutics-presents-results-from-digital-therapeutic-pilot-study-showing-nearly-50-reduction-in-anxiety/ 2022-10-24T07:01:14+00:00 https://medicaex.com/prnewswire/132nd-canton-fair-gives-full-play-to-the-advantages-of-chinas-medical-and-health-industry-to-provide-quality-health-care-choices/ 2022-10-24T07:00:48+00:00 https://medicaex.com/wp-content/uploads/2022/10/image_5003628_34769431-d22ZN8.jpeg https://medicaex.com/prnewswire/akesos-ivonescimab-pd-1-vegf-bsabs-granted-breakthrough-therapy-designation-by-china-nmpa-for-the-treatment-of-advanced-nsclc/ 2022-10-24T07:00:46+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo_Logo-naJ1AW.jpeg https://medicaex.com/prnewswire/gates-foundation-announces-1-27-billion-in-health-and-development-commitments-to-advance-progress-toward-the-global-goals/ 2022-10-21T22:00:19+00:00 https://medicaex.com/prnewswire/united-imaging-ships-global-installations-number-20000-20001-and-20002-from-its-houston-headquarters-to-new-york-city/ 2022-10-21T19:01:02+00:00 https://medicaex.com/prnewswire/grand-opening-of-medlab-asia-asia-health-2022-in-thailand/ 2022-10-21T19:00:43+00:00 https://medicaex.com/wp-content/uploads/2022/10/Wouter___Loy_copy-GidC2s.jpeg https://medicaex.com/prnewswire/antengene-announces-xpovio-regulatory-approval-in-taiwan-for-the-treatment-of-relapsed-and-or-refractory-multiple-myeloma-and-diffuse-large-b-cell-lymphoma/ 2022-10-21T13:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/10/ANTENGENE_EN_Logo-Lm6Bna.jpeg https://medicaex.com/prnewswire/ascend-continues-broad-expansion-into-new-markets-launches-hidura-med-portfolio/ 2022-10-21T12:00:40+00:00 https://medicaex.com/wp-content/uploads/2022/10/HiDuraMed-sEkNho.jpeg https://medicaex.com/prnewswire/bgi-australia-receives-nata-certification-for-clinical-whole-exome-sequencing/ 2022-10-21T12:00:27+00:00 https://medicaex.com/prnewswire/alfasigma-acquires-sofars-entire-share-capital-an-italian-pharmaceutical-company/ 2022-10-21T12:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/10/Alfasigma_Logo-CoJGVP.jpeg https://medicaex.com/prnewswire/after-30-years-new-guidelines-for-weight-loss-surgery/ 2022-10-21T11:00:24+00:00 https://medicaex.com/prnewswire/mgc-pharmaceuticals-successfully-developed-herbal-inspired-products-for-treatment-of-long-covid-and-covid-19/ 2022-10-21T09:00:19+00:00 https://medicaex.com/wp-content/uploads/2022/10/mgcpharma_logo-q4bUIg.jpeg https://medicaex.com/prnewswire/mgi-contributes-to-thailands-roadmap-for-genomic-medicine-in-genomics-thailand-initiative/ 2022-10-21T04:00:36+00:00 https://medicaex.com/prnewswire/health-and-wellness-deals-galore-this-october-with-reckitt-indonesias-lazada-super-brand-day/ 2022-10-21T04:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/10/image1-R3rD0y.jpeg https://medicaex.com/prnewswire/new-guinness-world-records-title-as-the-most-registered-blood-donation-with-over-70000-blood-donors-in-south-korea/ 2022-10-21T03:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/10/Blood_donation_record-r7bNP7.jpeg https://medicaex.com/prnewswire/img-announces-2022-leave-your-mark-contest-winners/ 2022-10-20T14:00:18+00:00 https://medicaex.com/wp-content/uploads/2022/10/International_Medical_Group_Logo-XN3oIV.jpeg https://medicaex.com/prnewswire/on-world-osteoporosis-day-take-five-steps-to-better-bone-health/ 2022-10-20T13:00:45+00:00 https://medicaex.com/prnewswire/aum-biosciences-and-asymchem-complete-phase-ii-api-production-campaign-of-novel-trk-inhibitor/ 2022-10-20T13:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/10/Asymchem_Logo-mODGJk.jpeg https://medicaex.com/prnewswire/official-ground-breaking-ceremony-of-wuhan-synthetic-biology-innovation-center-cabio-rd-center-investment-project/ 2022-10-20T13:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/10/Official_Ground_breaking_Ceremony_of_Wuhan_Synthetic_Biology_Innovation_Center___CABIO_R_D_Center_In-4t2Tuz.jpeg https://medicaex.com/prnewswire/biostarks-designated-as-official-biomarker-testing-kit-of-the-global-ironman-triathlon-series-and-title-partner-of-the-2022-ironman-arizona-triathlon-part-of-the-vinfast-ironman-u-s-series/ 2022-10-20T12:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/10/Biostarks_Logo-CfB1oz.jpeg https://medicaex.com/prnewswire/nccn-guidelines-for-patients-win-award-for-excellence-in-cancer-patient-education-from-cpen/ 2022-10-20T09:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/10/Shead-2sVVGj.jpeg https://medicaex.com/prnewswire/pharmabcine-announces-poster-presentations-on-its-anti-vista-antibody-candidate-at-sitc-2022/ 2022-10-20T08:01:00+00:00 https://medicaex.com/prnewswire/bgi-australia-receives-nata-certification-for-clinical-whole-exome-sequencing-2/ 2022-10-20T08:00:39+00:00 https://medicaex.com/prnewswire/clarivate-global-research-report-examines-role-of-research-assessment-with-a-review-of-six-regional-systems/ 2022-10-20T08:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/10/Clarivate_Logo-kD6YDP.jpeg https://medicaex.com/prnewswire/everest-medicines-announces-partner-providence-reports-positive-top-line-data-from-phase-2-primary-immunization-trial-for-mrna-covid-19-vaccine-candidate-in-adults/ 2022-10-20T07:00:42+00:00 https://medicaex.com/prnewswire/brii-biosciences-presents-promising-clinical-data-to-support-ongoing-development-of-novel-hiv-therapeutic-candidates-at-idweek-2022/ 2022-10-20T07:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/10/Logo-2YhlHC.jpeg https://medicaex.com/prnewswire/millions-of-women-who-suffer-from-pelvic-pain-still-unaware-of-pelvic-venous-congestion-syndrome-pvcs/ 2022-10-20T03:00:21+00:00 https://medicaex.com/prnewswire/consumer-healthcare-products-chp-australia-streamlines-content-management-for-life-sciences-companies-with-veeva-vault-promomats/ 2022-10-20T00:00:19+00:00 https://medicaex.com/wp-content/uploads/2022/10/Logo-Dhb3Mc.jpeg https://medicaex.com/prnewswire/telix-reports-third-quarter-2022-financial-results/ 2022-10-19T23:00:40+00:00 https://medicaex.com/wp-content/uploads/2022/10/Telix_Main_Logo_Logo-sjd6FF.jpeg https://medicaex.com/prnewswire/standigm-to-attend-bio-europe-2022/ 2022-10-19T13:00:47+00:00 https://medicaex.com/wp-content/uploads/2022/10/Standigm_B_W_Logo-Br6LOV.jpeg https://medicaex.com/prnewswire/wetrade-group-to-increase-presence-in-the-health-market/ 2022-10-19T13:00:33+00:00 https://medicaex.com/prnewswire/translumina-further-strengthens-senior-leadership-to-drive-next-phase-of-growth/ 2022-10-19T12:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/10/Translumina_Logo-jOOZ3Q.jpeg https://medicaex.com/prnewswire/axiomtek-unleashes-ip69k-ip66-rated-10-4-stainless-steel-fanless-touch-panel-computer-for-food-processing-industry-got810-316/ 2022-10-19T12:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/10/image_5019367_29542991-tve7WZ.jpeg https://medicaex.com/prnewswire/rhovac-board-member-resigns-due-to-health-reasons/ 2022-10-19T12:00:27+00:00 https://medicaex.com/prnewswire/onesolution-expends-her-iot-solution-into-dental-care-market/ 2022-10-19T12:00:17+00:00 https://medicaex.com/prnewswire/sirnaomics-to-present-latest-developments-on-galahead-therapeutic-platform-at-upcoming-industry-conferences/ 2022-10-19T08:00:28+00:00 https://medicaex.com/prnewswire/united-imaging-installs-broward-countys-first-umi-550-at-holy-cross-health-in-fort-lauderdale/ 2022-10-19T07:00:52+00:00 https://medicaex.com/prnewswire/parexel-recognized-by-frost-sullivan-with-2022-global-customer-value-leadership-award/ 2022-10-19T03:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/10/Parexel_Award_Logo-0Z0RCh.jpeg https://medicaex.com/prnewswire/gracell-biotechnologies-doses-first-patient-in-phase-2-portion-of-registrational-phase-1-2-clinical-trial-evaluating-gc007g-for-treatment-of-b-cell-acute-lymphoblastic-leukemia/ 2022-10-19T03:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/10/gracell_logo_Logo-lhBFKh.jpeg https://medicaex.com/prnewswire/award-winning-skinpen-precision-announces-new-and-expanded-approved-indications/ 2022-10-19T00:00:37+00:00 https://medicaex.com/wp-content/uploads/2022/10/Crown_Logo-HDu7C1.jpeg https://medicaex.com/prnewswire/value-of-tissue-analytics-for-remote-care-highlighted-in-research-from-australian-virtual-wound-care-program/ 2022-10-18T20:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/10/Net_Health_Systems_Logo-mosD2w.jpeg https://medicaex.com/prnewswire/alterity-therapeutics-launches-ath434-phase-2-clinical-trial-in-australia-for-the-treatment-of-individuals-with-multiple-system-atrophy/ 2022-10-18T13:00:52+00:00 https://medicaex.com/wp-content/uploads/2022/10/Alterity_Logo-01nE0f.jpeg https://medicaex.com/prnewswire/collaboration-between-drug-and-medical-food-manufacturers-to-boost-markets-growth/ 2022-10-18T13:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/10/Medical_Food-TYS9fj.jpeg https://medicaex.com/prnewswire/kira-pharmaceuticals-to-present-first-in-human-clinical-data-at-american-society-for-nephrology-kidney-week-2022/ 2022-10-18T13:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/10/Kira_US_Logo-RMuiUt.jpeg https://medicaex.com/prnewswire/alphyn-biologics-announces-enrollment-passes-halfway-point-in-phase2a-clinical-trial-of-mild-to-moderate-atopic-dermatitis-treatment/ 2022-10-18T12:00:44+00:00 https://medicaex.com/wp-content/uploads/2022/10/Alphyn_Biologics__LLC__Logo_Hi_Res_Transparent_Bckgrd_Logo-iyr9gG.jpeg https://medicaex.com/prnewswire/csafe-continues-expansion-of-its-temperature-controlled-shipping-solutions-portfolio-with-introduction-of-advanced-reusable-pallet-shipper/ 2022-10-18T12:00:15+00:00 https://medicaex.com/wp-content/uploads/2022/10/CSafe_1920x1080_APS_Double_warehouse-pYo7Qe.jpeg https://medicaex.com/prnewswire/harbour-biomed-announces-upcoming-poster-presentations-at-the-37th-society-for-immunotherapy-of-cancer-annual-meeting/ 2022-10-18T11:00:58+00:00 https://medicaex.com/wp-content/uploads/2022/10/HB_for_email_Logo-IvAAIf.jpeg https://medicaex.com/prnewswire/wetrade-group-announces-the-launch-of-global-payment-system-wtpay-and-development-plan-of-health-business/ 2022-10-18T10:00:16+00:00 https://medicaex.com/wp-content/uploads/2022/10/1-ZGYRtS.jpeg https://medicaex.com/prnewswire/immvira-announced-to-launch-the-construction-of-global-rd-and-commercialization-base/ 2022-10-18T09:00:15+00:00 https://medicaex.com/wp-content/uploads/2022/10/image-34Lv5a.jpeg https://medicaex.com/prnewswire/intron-developed-advanced-bacteriophage-engineering-platform-technology-based-on-modified-random-mutagenesis/ 2022-10-18T05:00:32+00:00 https://medicaex.com/prnewswire/innovent-announces-phase-ib-results-of-higher-dose-mazdutide-ibi362-in-chinese-participants-with-overweight-or-obesity-published-in-eclinicalmedicine/ 2022-10-18T03:00:33+00:00 https://medicaex.com/prnewswire/icbe-emf-submits-wireless-technology-not-adequately-assessed-for-hazards-to-human-health-and-environment/ 2022-10-18T01:00:16+00:00 https://medicaex.com/prnewswire/actinogen-medical-limited-acw-announces-large-xanamem-therapeutic-effect-in-early-stage-alzheimers-disease-ad-patients/ 2022-10-18T00:00:44+00:00 https://medicaex.com/prnewswire/mediterranean-diet-improves-immunotherapy-response-rates-and-progression-free-survival-in-advanced-melanoma-new-study-presented-at-ueg-week-suggests/ 2022-10-17T22:00:41+00:00 https://medicaex.com/prnewswire/kira-pharmaceuticals-announces-ind-approval-from-chinese-nmpa-for-phase-2-evaluation-of-kp104-in-paroxysmal-nocturnal-hemoglobinuria-pnh/ 2022-10-17T22:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/10/Kira_Pharmaceuticals_Logo-kfgqfv.jpeg https://medicaex.com/prnewswire/chinese-nmpa-approves-study-of-telix-kidney-cancer-imaging-candidate/ 2022-10-17T16:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/10/Telix_Logo-Qo0YQq.jpeg https://medicaex.com/prnewswire/hugel-resubmits-bla-for-its-botulinum-toxin-botulax-to-the-u-s-fda/ 2022-10-17T12:00:48+00:00 https://medicaex.com/wp-content/uploads/2022/10/Logo_of_Hugel_Logo-8iDksx.jpeg https://medicaex.com/prnewswire/tianfu-international-biocity-build-global-bioindustry-city/ 2022-10-17T12:00:26+00:00 https://medicaex.com/prnewswire/pacertool-establishes-world-class-scientific-advisory-board/ 2022-10-17T11:00:35+00:00 https://medicaex.com/prnewswire/fosun-pharmas-msci-esg-rating-upgraded-to-a/ 2022-10-17T11:00:25+00:00 https://medicaex.com/prnewswire/transcenta-to-present-two-scientific-posters-at-sitc-2022-annual-meeting/ 2022-10-17T09:00:25+00:00 https://medicaex.com/prnewswire/first-patient-treated-in-claritys-therapeutic-prostate-cancer-trial/ 2022-10-17T05:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/10/Clarity_Large_Logo_high_res_ID_42691c6bc5c0_Logo-rNa7NF.jpeg https://medicaex.com/prnewswire/detectedx-to-provide-free-access-to-radiology-online-learning-platform-to-radiology-across-borders-to-enhance-global-charitys-teaching-initiatives/ 2022-10-17T05:00:34+00:00 https://medicaex.com/wp-content/uploads/2022/10/detectedx_Logo-UdAkRD.jpeg https://medicaex.com/prnewswire/taurx-announces-results-from-phase-3-alzheimers-disease-study-lucidity-assuring-path-for-regulatory-submissions/ 2022-10-16T23:00:41+00:00 https://medicaex.com/prnewswire/first-in-north-america-jolly-good-hosts-clinical-vr-multi-seminar-in-boston-aiming-for-mass-production-of-ugc-medical-vr/ 2022-10-16T23:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/10/1-RYJhyX.jpeg https://medicaex.com/prnewswire/neurophth-therapeutics-conducts-special-interview-with-dr-satoshi-kashii-on-world-sight-day/ 2022-10-16T17:00:44+00:00 https://medicaex.com/wp-content/uploads/2022/10/Neurophth_Logo-XSxJHb.jpeg https://medicaex.com/prnewswire/experts-from-the-global-hygiene-council-ghc-call-for-investment-in-hand-hygiene-to-save-lives/ 2022-10-15T00:00:17+00:00 https://medicaex.com/wp-content/uploads/2022/10/Global_Hygiene_Council_Logo-ID1eYI.jpeg https://medicaex.com/prnewswire/pentax-medical-launches-the-c2-cryoballoontm-ablation-system-in-canada-for-the-treatment-of-barretts-esophagus/ 2022-10-14T21:00:22+00:00 https://medicaex.com/prnewswire/hanalls-second-fcrn-inhibitor-hl161ans-to-be-added-to-the-development-program-of-its-licensed-partner/ 2022-10-14T13:00:59+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-dJ9goc.jpeg https://medicaex.com/prnewswire/2022-tang-prize-masters-forum-series-sheds-light-on-current-global-challenges/ 2022-10-14T09:00:20+00:00 https://medicaex.com/prnewswire/wuxi-biologics-receives-best-cdmo-award-of-the-year/ 2022-10-14T02:00:24+00:00 https://medicaex.com/prnewswire/samsung-biologics-obtains-three-global-iso-certifications/ 2022-10-14T00:00:39+00:00 https://medicaex.com/wp-content/uploads/2022/10/Image__Samsung_Biologics_obtains_three_global_ISO_certifications-6aW4Ga.jpeg https://medicaex.com/prnewswire/aerorx-partners-with-hcmed-to-develop-a-nebulized-laba-lama-combination-solution-for-the-treatment-of-chronic-obstructive-pulmonary-disease/ 2022-10-13T14:01:08+00:00 https://medicaex.com/prnewswire/guiyangs-wudang-district-shines-in-pharma-sector/ 2022-10-13T14:00:50+00:00 https://medicaex.com/wp-content/uploads/2022/10/Guiyang_Xintian_Pharmaceutical_Co_experiencing_rapid_growth_stock_market_listing-tRFONg.jpeg https://medicaex.com/prnewswire/kintor-pharma-announces-publication-of-phase-ib-data-from-pruxelutamide-for-ar-mbc-in-ejc/ 2022-10-13T13:01:04+00:00 https://medicaex.com/prnewswire/concord-medical-announces-changes-in-management/ 2022-10-13T13:00:55+00:00 https://medicaex.com/prnewswire/anbogen-therapeutics-receives-approval-from-u-s-fda-for-phase-ib-ii-protocol-amendment-for-abt-101/ 2022-10-13T13:00:47+00:00 https://medicaex.com/prnewswire/remegen-receives-orphan-drug-designation-from-fda-for-telitacicept-for-the-treatment-of-myasthenia-gravis/ 2022-10-13T13:00:44+00:00 https://medicaex.com/prnewswire/nomination-committee-has-been-appointed-for-mentice-ab-publ-annual-general-meeting-2023/ 2022-10-13T12:00:53+00:00 https://medicaex.com/prnewswire/gerresheimer-reports-double-digit-growth-in-revenue-and-earnings-for-the-third-quarter/ 2022-10-13T12:00:43+00:00 https://medicaex.com/prnewswire/wishing-on-a-star-how-celebs-like-varun-dhawan-are-coming-together-to-help-11-year-old-zeus-fight-cancer/ 2022-10-13T12:00:42+00:00 https://medicaex.com/prnewswire/galderma-announces-intention-to-expand-manufacturing-and-innovation-footprint-in-asia-pacific/ 2022-10-13T12:00:37+00:00 https://medicaex.com/prnewswire/ichnos-sciences-announces-initiation-of-first-in-human-study-for-isb-1442/ 2022-10-13T11:01:14+00:00 https://medicaex.com/wp-content/uploads/2022/10/Ichnos_Logo-Zgouph.jpeg https://medicaex.com/prnewswire/wuxi-biologics-and-toregem-biopharma-sign-mou-for-development-of-anti-usag-1-antibody/ 2022-10-13T11:00:59+00:00 https://medicaex.com/prnewswire/tvm-capital-healthcare-and-siemens-healthineers-announce-strategic-collaboration-to-advance-healthcare-access-in-southeast-asia/ 2022-10-13T11:00:59+00:00 https://medicaex.com/wp-content/uploads/2022/10/Left_right__Present_TVM_Healthcare_Institute_event_Siemens_Healthineers_Managing-lAkGv9.jpeg https://medicaex.com/prnewswire/german-chancellor-scholz-who-director-general-tedros-international-ministers-at-world-health-summit-2022/ 2022-10-13T07:00:32+00:00 https://medicaex.com/prnewswire/xsensor-earns-the-frost-sullivan-2022-technology-innovation-leadership-award-for-intelligent-dynamic-sensing-systems/ 2022-10-13T06:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/10/XSENSOR_Award-KTbEBd.jpeg https://medicaex.com/prnewswire/csafe-and-biolife-solutions-inc-announce-partnership-to-expand-supply-chain-solutions-for-the-cell-and-gene-therapy-market/ 2022-10-13T02:00:38+00:00 https://medicaex.com/wp-content/uploads/2022/10/BioLife_Solutions_DV10-wOnY7w.jpeg https://medicaex.com/prnewswire/great-bay-bio-announces-official-launch-of-site-specific-integration-platform-for-cell-line-development-alfacell/ 2022-10-13T00:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/10/image_5012991_24491279-ifOKQZ.jpeg https://medicaex.com/prnewswire/aldatu-biosciences-adds-another-outbreak-disease-to-pandemic-preparedness-portfolio/ 2022-10-12T16:00:33+00:00 https://medicaex.com/prnewswire/advanced-instruments-introduces-solentim-vips-pro-a-high-efficiency-single-cell-seeder-to-optimize-cell-line-development-workflows/ 2022-10-12T13:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/10/VIPS_PRO_Beauty_Shot__Small-f0PeDv.jpeg https://medicaex.com/prnewswire/samsung-biologics-unlocks-additional-capacity-for-production-at-its-newest-plant-4/ 2022-10-12T13:00:22+00:00 https://medicaex.com/prnewswire/hanalls-licensed-partner-in-china-enters-sublicense-agreement-with-cspc-to-further-accelerate-development-of-batoclimab/ 2022-10-12T13:00:22+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-JGX2kP.jpeg https://medicaex.com/prnewswire/dr-ivan-puah-liposuction-doctor-in-singapore-shares-the-secret-to-achieving-a-good-liposuction-result/ 2022-10-12T04:00:33+00:00 https://medicaex.com/prnewswire/pharming-submits-a-marketing-authorisation-application-to-the-european-medicines-agency-for-leniolisib/ 2022-10-12T03:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/10/Pharming_Group_NV_Logo-sdaE4D.jpeg https://medicaex.com/prnewswire/maybelline-ny-launches-free-mental-health-training-in-colleges/ 2022-10-12T00:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/10/Brave_Talk-hfQUnU.jpeg https://medicaex.com/prnewswire/emeterm-anti-nausea-wristband-undergoes-clinical-study-for-prevent-of-postoperative-nausea-and-vomiting/ 2022-10-11T16:00:35+00:00 https://medicaex.com/wp-content/uploads/2022/10/EmeTerm_Anti_Nausea_Wristband_Undergoes_Clinical_Study_Prevent_Postoperative_Nausea_Vomiting-FMPVNT.jpeg https://medicaex.com/prnewswire/jw-therapeutics-announces-nmpa-approval-of-relmacabtagene-autoleucel-injection-in-patients-with-relapsed-or-refractory-follicular-lymphoma/ 2022-10-11T14:00:23+00:00 https://medicaex.com/prnewswire/pierre-fabre-is-taking-a-minority-stake-via-its-dedicated-investment-subsidiary-pierre-fabre-invest-in-gennisium-pharma-an-innovative-company-specializing-in-medicines-for-premature-newborns-and-ni/ 2022-10-11T12:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/10/Pierre_Fabre_Gennisium__Logo-JLnZA5.jpeg https://medicaex.com/prnewswire/portfolio-highlights-clinical-and-financial-updates-of-abm-f5-acelink-haya-regenacy-and-arthrosi/ 2022-10-11T11:00:38+00:00 https://medicaex.com/prnewswire/the-china-nmpa-approves-selpercatinib-for-the-treatment-of-patients-with-ret-driven-lung-and-thyroid-cancers/ 2022-10-11T11:00:23+00:00 https://medicaex.com/prnewswire/the-china-nmpa-approved-cyramza-ramucirumab-for-the-treatment-in-patients-with-hepatocellular-carcinoma/ 2022-10-11T11:00:23+00:00 https://medicaex.com/prnewswire/integrating-fitbit-mindfi-app-into-daily-lifestyle-leads-to-significant-improvements-in-teachers-mental-wellness-singapore-study/ 2022-10-11T10:00:21+00:00 https://medicaex.com/wp-content/uploads/2022/10/MindFi_Logo-jrKE0j.jpeg https://medicaex.com/prnewswire/wuxi-biologics-co-ltd-removed-from-unverified-list/ 2022-10-11T05:00:23+00:00 https://medicaex.com/prnewswire/the-asia-pacific-enterprise-awards-2022-vietnam-honors-business-leaders-and-enterprises-spearheading-vietnams-exceptional-growth/ 2022-10-11T04:00:16+00:00 https://medicaex.com/prnewswire/waterdrop-inc-ceo-shen-peng-attends-future-china-global-forum-2022/ 2022-10-10T15:00:29+00:00 https://medicaex.com/prnewswire/evowera-launches-planck-mini-a-smart-new-manual-toothbrush/ 2022-10-10T14:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/10/planck_mini_kv-wYOt0K.jpeg https://medicaex.com/prnewswire/mindray-showcases-hematology-innovations-and-academic-achievements-to-the-world-at-islh-2022/ 2022-10-10T13:00:47+00:00 https://medicaex.com/wp-content/uploads/2022/10/01-0cRwLn.jpeg https://medicaex.com/prnewswire/everest-medicines-announces-approval-of-xerava-in-hong-kong-for-the-treatment-of-complicated-intra-abdominal-infections/ 2022-10-10T12:00:24+00:00 https://medicaex.com/prnewswire/antengene-announces-upcoming-presentations-at-the-2022-society-for-immunotherapy-of-cancer-annual-meeting/ 2022-10-10T12:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/10/ANTENGENE_EN_Logo-kGiAMX.jpeg https://medicaex.com/prnewswire/ascletis-announces-dosing-of-24-healthy-subjects-of-the-first-3-cohorts-in-multiple-dose-escalation-phase-i-clinical-trial-of-oral-rdrp-inhibitor-asc10-for-covid-19/ 2022-10-10T01:00:26+00:00 https://medicaex.com/prnewswire/sciwind-biosciences-announces-initiation-of-dosing-in-phase-1-clinical-trial-evaluating-xw014-an-oral-small-molecule-glp-1-receptor-agonist-for-the-treatment-of-obesity-and-type-2-diabetes/ 2022-10-10T01:00:26+00:00 https://medicaex.com/prnewswire/synapse-medicine-initiates-multi-site-implementation-study-with-leading-u-s-hospitals/ 2022-10-10T00:00:38+00:00 https://medicaex.com/wp-content/uploads/2022/10/Synapse_Medicine_Logo-x1iIsX.jpeg https://medicaex.com/prnewswire/axa-betterme-weekend-concludes-on-a-high-note/ 2022-10-09T12:00:18+00:00 https://medicaex.com/wp-content/uploads/2022/10/01_PRN_photo_Entrance-5umIQx.jpeg https://medicaex.com/prnewswire/first-patient-in-australia-dosed-with-illuccix-telixs-approved-prostate-cancer-imaging-agent/ 2022-10-08T22:00:42+00:00 https://medicaex.com/prnewswire/cytiva-strengthens-cell-line-development-with-cevec-acquisition/ 2022-10-08T22:00:24+00:00 https://medicaex.com/prnewswire/the-outbreak-of-covid-19-unlocked-the-demand-for-antimicrobial-technologies/ 2022-10-08T07:00:18+00:00 https://medicaex.com/wp-content/uploads/2022/10/Antimicrobial_Technologies-LtqdKZ.jpeg https://medicaex.com/prnewswire/servier-unveils-its-2030-ambition-and-reveals-a-new-visual-identity/ 2022-10-08T02:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/10/Servier_Logo-xobLra.jpeg https://medicaex.com/prnewswire/harbour-biomed-announces-first-subject-dosed-in-phase-i-study-of-next-gen-anti-tslp-fully-human-monoclonal-antibody/ 2022-10-07T13:00:54+00:00 https://medicaex.com/wp-content/uploads/2022/10/HB_for_email_Logo-MISgVL.jpeg https://medicaex.com/prnewswire/transcenta-received-ind-clearance-from-fda-for-its-best-in-class-masp2-targeting-antibody-tst004-for-the-treatment-of-iga-nephropathy/ 2022-10-07T13:00:39+00:00 https://medicaex.com/prnewswire/raffles-medical-group-and-nalagenetics-provide-pre-emptive-genetic-testing-for-adverse-drug-reactions/ 2022-10-07T10:00:22+00:00 https://medicaex.com/prnewswire/havas-health-you-appoints-paul-pfleiderer-as-president-of-havas-life-new-york/ 2022-10-07T09:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/10/HH_Y_Logo_Logo-MjNzlC.jpeg https://medicaex.com/prnewswire/revitalash-cosmetics-champions-breast-cancer-awareness-research-and-support-worldwide-with-2022-pink-program-announcement/ 2022-10-07T09:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/10/RL_BCA-1hsMKl.jpeg https://medicaex.com/prnewswire/medit-wins-four-consecutive-patent-lawsuits-against-3shape/ 2022-10-07T07:00:13+00:00 https://medicaex.com/wp-content/uploads/2022/10/IOS_family_3_rv-HCa78Y.jpeg https://medicaex.com/prnewswire/everise-named-to-newsweeks-list-of-the-top-100-most-loved-workplaces-for-2022/ 2022-10-06T22:00:15+00:00 https://medicaex.com/wp-content/uploads/2022/10/EVERISE_Logo-o6ihDf.jpeg https://medicaex.com/prnewswire/mgi-launches-ultra-high-speed-dnbseq-g99-gene-sequencer-with-mid-to-low-range-throughput-2/ 2022-10-06T16:00:36+00:00 https://medicaex.com/prnewswire/neurophth-announces-first-patient-dosed-in-phase-iii-clinical-trial-for-the-gene-therapy-treatment-of-lhon/ 2022-10-06T10:00:37+00:00 https://medicaex.com/wp-content/uploads/2022/10/Neurophth_Logo-QBHgG3.jpeg https://medicaex.com/prnewswire/isyncwave-eeg-scanner-receives-fda-510k-clearance/ 2022-10-06T06:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/10/image_1-rRTUzO.jpeg